MAPK-IN-6
MAPK-IN-6 is a blood-brain barrier-permeable MAPK inhibitor. MAPK-IN-6 inhibits oxidative stress-induced activation of the MAPK signaling cascade, including the phosphorylation of ERK1/2, p38 and JNK. MAPK-IN-6 eliminates intracellular reactive oxygen species (ROS) accumulation, stabilizes mitochondrial membrane potential and inhibits cell apoptosis. MAPK-IN-6 can be used for the research of ischemic stroke.
For research use only. We do not sell to patients.
- Formula: C21H24O10
- Molecular Weight:436.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
|
p38 |
ERK1 |
ERK2 |
Caspase 3 |
In Vitro
MAPK-IN-6 (Compound 116B) (10 nM-200 μM; 24 h) exhibits cytocompatibility with SH-SY5Y neuronal cells at concentrations up to 100 μM, and maintains over 90% cell viability[1].
MAPK-IN-6 (10 nM-50 μM; 24 h) exhibits significant neuroprotective activity and preserves cell membrane integrity in H2O2 (400 μM)-stressed SH-SY5Y neuronal cells, and significantly reduces the release of lactate dehydrogenase (LDH)[1].
MAPK-IN-6 (1 μM; 24 h) promotes cell survival, reduces the level of total intracellular reactive oxygen species (ROS), decreases mitochondrial superoxide accumulation, stabilizes mitochondrial membrane potential, maintains mitochondrial morphology, preserves nuclear integrity, inhibits apoptosis, blocks the MAPK cascade, and downregulates the expression of pro-inflammatory factors and enzymes in H2O2 (400 μM)-stressed SH-SY5Y neuronal cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SH-SY5Y cells
-
Concentration:10 nM, 50 nM, 100 nM, 200 nM, 500 nM, 1.0 μM, 5 μM, 10 μM, 50 μM, 100 μM, 200 μM
-
Incubation Time:24 h
-
Result:Demonstrated excellent cytocompatibility.
The cell survival rate remained above 90% even at a high concentration of 100 μM.
-
Cell Line:SH-SY5Y cells
-
Concentration:10 nM, 50 nM, 100 nM, 200 nM, 500 nM, 1.0 μM, 5 μM, 10 μM, 50 μM
-
Incubation Time:Pretreatment for 24 h, followed by co-incubation with 400 μM H2O2 for 2 h
-
Result:Effectively rescued cells from oxidative stress-induced death.
A dose of 1 μM restored cell viability to approximately 89.4%.
-
Cell Line:SH-SY5Y cells
-
Concentration:1 μM
-
Incubation Time:Pretreatment for 24 h, followed by H2O2 exposure
-
Result:Significantly suppressed the expression of pro-apoptotic proteins (Caspase 3, Cleaved Caspase 3, Bax).
Significantly upregulated the level of the anti-apoptotic protein (BCL-XL).
significantly attenuated the signal activation induced by oxidative stress.
Markedly reduced the phosphorylation levels of ERK1/2, p38, and JNK kinases.
-
Cell Line:SH-SY5Y cells
-
Concentration:1 μM
-
Incubation Time:Pretreatment for 24 h, followed by H2O2 exposure
-
Result:Exerted broad anti-inflammatory effects at the transcriptional level.
Significantly downregulated the mRNA expression of TNF-α, IL-1β, IL-6, iNOS, and COX-2.
In Vivo
MAPK-IN-6 (5 mg/kg; i.p.; single administration) exhibits the ability to successfully cross the blood-brain barrier (BBB) and reach effective concentrations in brain tissues in normal rat models[1].
MAPK-IN-6 (1-10 mg/kg; i.p.; single administration; 3 days) exhibits excellent in vivo safety in normal rat models, causing no observable organ toxicity or structural abnormalities in the liver, kidney, or spleen[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Transient bilateral common carotid artery occlusion reperfusion (tBCCAO/R) rat model. Bilateral common carotid arteries were sequentially occluded for 30 minutes, followed by a 5-minute interruption of blood flow, two additional 3-second clamping cycles, and subsequent reperfusion[1]
-
Dosage:5 mg/kg
-
Administration:i.p.; single dose
-
Result:Reduced the cerebral infarct volume and effectively decreased the modified neurological severity scores (mNSS).
Improved ischemia-induced motor incoordination, reducing the number of falls in the rotarod test and shortening the completion time in pole and balance beam tests.
Alleviated post-stroke anxiety and depressive-like behaviors by increasing time spent in the central zone during the open field test and enhancing sucrose consumption in the sucrose preference test.
Preserved neuronal morphology in the cortex and striatum, reduced pyknosis and neurodegeneration, and largely increased the ratio of surviving neurons.
Suppressed the pathological activation of astrocytes (GFAP, S100β) and microglia (IBA1) in cortical and striatal regions, reversing their transition into hypertrophic or amoeboid forms.
Upregulated the gene expression of endogenous antioxidant enzymes (SOD1, CAT, GPx4) in the cortex and striatum, reversing oxidative stress injury.
-
Animal Model:Normal healthy rat model[1]
-
Dosage:5 mg/kg
-
Administration:i.p.; single dose
-
Result:Successfully penetrated the blood-brain barrier, exhibiting a distinct mass spectrometry peak in brain extracts with an estimated penetration concentration of 3.68 μM.
-
Animal Model:Normal healthy rat model[1]
-
Dosage:1 mg/kg, 5 mg/kg, 10 mg/kg
-
Administration:i.p.; single dose; 3 days
-
Result:Caused no morphological damage or tissue necrosis to the kidneys, liver, and spleen, demonstrating excellent in vivo organ compatibility.
Chemical Information
-
Molecular Weight 436.41
-
Formula C21H24O10
-
SMILES
O=C1C2=C(C=CO2)C3=C(OC)C(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)=C(OC)C=C3CC1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)